Tong X - Search Results

1

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression.

You Z, Fischer DC, Tong X, Hasenburg A, Aguilar-Cordova E, Kieback DG. You Z, et al. Among authors: tong x. Cancer Gene Ther. 2001 Mar;8(3):168-75. doi: 10.1038/sj.cgt.7700284. Cancer Gene Ther. 2001. PMID: 11332987

2

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer.

Kieback DG, Fischer DC, Engehausen DG, Sauerbrei W, Oehler MK, Tong XW, Aguilar-Cordova E. Kieback DG, et al. Cancer Gene Ther. 2002 May;9(5):478-81. doi: 10.1038/sj.cgt.7700462. Cancer Gene Ther. 2002. PMID: 11961671

3

The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter.

Tong X, Engehausen DG, Freund CT, Agoulnik I, Guo Z, Oehler MK, Kim TE, Hasenburg A, Contant CF, Woo SL, Kieback DG. Tong X, et al. Anticancer Res. 1998 Mar-Apr;18(2A):719-25. Anticancer Res. 1998. PMID: 9615711

4

Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents.

Tong X, Shine DH, Agoulnik I, Freund CT, Hasenburg A, Aguilar-Cordova E, Woo SL, Kieback DG. Tong X, et al. Anticancer Res. 1998 Sep-Oct;18(5A):3421-6. Anticancer Res. 1998. PMID: 9858918

5

Comparison of long-term survival of cytomegalovirus promotre versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer.

Tong X, Engehausen DG, Freund CT, Agoulnik I, Oehler MK, Kim TE, Hasenburg A, Guo Z, Contant CF, Woo SL, Kieback DG. Tong X, et al. Hybridoma. 1999 Feb;18(1):93-7. doi: 10.1089/hyb.1999.18.93. Hybridoma. 1999. PMID: 10211795

6

Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir.

Tong XW, Block A, Chen SH, Woo SL, Kieback DG. Tong XW, et al. Anticancer Res. 1996 Jul-Aug;16(4A):1611-7. Anticancer Res. 1996. PMID: 8712678

7

Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy.

Tong XW, Agoulnik I, Blankenburg K, Contant CF, Hasenburg A, Runnebaum LB, Stickeler E, Kaplan AL, Woo SL, Kieback DG. Tong XW, et al. Anticancer Res. 1997 Mar-Apr;17(2A):811-3. Anticancer Res. 1997. PMID: 9137412

8

Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy.

Tong XW, Engehausen DG, Kaufman RH, Agoulnik I, Contant C, Freund CT, Oehler MK, Kim TE, Hasenburg A, Woo SL, Kieback DG. Tong XW, et al. Anticancer Res. 1998 Mar-Apr;18(2A):713-8. Anticancer Res. 1998. PMID: 9615710

9

Molecular aspects of ovarian cancer. Is gene therapy the solution?

Tong XW, Kieback DG, Ramesh R, Freeman SM. Tong XW, et al. Hematol Oncol Clin North Am. 1999 Feb;13(1):109-33, viii. doi: 10.1016/s0889-8588(05)70156-8. Hematol Oncol Clin North Am. 1999. PMID: 10080072 Review.

10

Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer.

Hasenburg A, Tong XW, Rojas-Martinez A, Nyberg-Hoffman C, Kieback CC, Kaplan A, Kaufman RH, Ramzy I, Aguilar-Cordova E, Kieback DG. Hasenburg A, et al. Among authors: tong xw. Cancer Gene Ther. 2000 Jun;7(6):839-44. doi: 10.1038/sj.cgt.7700192. Cancer Gene Ther. 2000. PMID: 10880013 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,218 results

Search Page

Filters